Flayou Kaoutar, Ouzeddoun Naima, Bayahia Rabia, Rhou Hakima, Benamar Loubna
Nephrology-Dialysis-Renal Transplantation Department, Ibn Sina University Hospital, Rabat, Morocco.
Saudi J Kidney Dis Transpl. 2016 Jan;27(1):107-10. doi: 10.4103/1319-2442.174089.
Peritoneal dialysis is a new renal replacement therapy recently introduced in Morocco since 2006. Continuous ambulatory peritoneal dialysis has proven to be as effective as hemodialysis. However, it is associated with several complications. The aim of this study was to evaluate the outcome of complications in patients treated with peritoneal dialysis at our center. The nature of non-infectious complications was noted during follow-up in these patients. Fiftyseven complications were noted among 34 patients between June 2006 and June 2014. Catheter migration was the most common complication (36.8%), followed by obstruction (14%), dialysate leaks (14%), hemorrhagic complications (10.5%) and, finally, hernia (12.2%), catheter perforation (5.2%) and externalization (3.5%).
腹膜透析是自2006年起在摩洛哥新近引入的一种肾脏替代疗法。持续性非卧床腹膜透析已被证明与血液透析一样有效。然而,它会引发多种并发症。本研究的目的是评估在我们中心接受腹膜透析治疗的患者并发症的发生情况。在对这些患者的随访过程中记录了非感染性并发症的情况。2006年6月至2014年6月期间,34例患者共出现57种并发症。导管移位是最常见的并发症(36.8%),其次是梗阻(14%)、透析液渗漏(14%)、出血性并发症(10.5%),最后是疝(12.2%)、导管穿孔(5.2%)和导管外露(3.5%)。